Concepedia

Publication | Open Access

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial

DOIFull Paper Access

202

Citations

21

References

2018

Year

Philip J. Mease, Laura C. Coates, Philip Helliwell, Mykola Stanislavchuk, Anna Rychlewska-Hańczewska, Anna Dudek, Walid Abi‐Saab, Chantal Tasset, Luc Meuleners, Pille Harrison,
The Lancet

Abstract

Galapagos and Gilead Sciences.

References

YearCitations

Page 1